Finance

Lists
NKGN:OTCMKTS
NKGen Biotech Inc
0,011 US$
-0,90%
(-0,000100) 1D
16 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NKGN...
Open
0,01 US$
High
0,01 US$
Low
0,01 US$
Mkt. cap
1,44 მლნ.
Avg. vol.
3,21 ათ.
Volume
8,00 ათ.
52-wk high
0,20 US$
52-wk low
0,00 US$
Beta
1,69
Shares outstanding
130,60 მლნ.
No. of employees
26
Open
0,01 US$
High
0,01 US$
Low
0,01 US$
Mkt. cap
1,44 მლნ.
Avg. vol.
3,21 ათ.
Volume
8,00 ათ.
52-wk high
0,20 US$
52-wk low
0,00 US$
Beta
1,69
Shares outstanding
130,60 მლნ.
No. of employees
26
News stories
From web sources and news partners
About NKGen Biotech Inc
CEO-
Employees26
Founded2017
Headquartersსანტა-ანა, კალიფორნია, ამერიკის შეერთებული შტატები
Sector-
Websitenkgenbiotech.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2024
დეკ. 2024
მარ. 2025
Revenue
-
-
-
Cost of goods sold
-
-
-
Cost of revenue
-
-
-
Research and development expenses
2,78 მლნ.
1,56 მლნ.
1,86 მლნ.
Total research and development expenses
-
-
-
Selling, general, and admin expenses
4,01 მლნ.
3,54 მლნ.
2,81 მლნ.
Operating expense
6,79 მლნ.
5,10 მლნ.
4,67 მლნ.
Total operating expenses
6,79 მლნ.
5,10 მლნ.
4,67 მლნ.
Operating income
-6,79 მლნ.
-5,10 მლნ.
-4,67 მლნ.
Other non operating income
-2,99 მლნ.
-8,79 მლნ.
20,52 მლნ.
EBT including unusual items
6,60 მლნ.
-29,36 მლნ.
15,35 მლნ.
EBT excluding unusual items
-10,25 მლნ.
-14,43 მლნ.
15,35 მლნ.
Income tax expense
-
53,00 ათ.
-
Effective tax rate
-
-0,18%
-
Other operating expenses
-
-
-
Net income
6,60 მლნ.
-29,41 მლნ.
15,35 მლნ.
Net profit margin
-
-
-
Earnings per share
-
-
-
Interest and investment income
-
-
-
Interest expense
-472,00 ათ.
-536,00 ათ.
-509,00 ათ.
Net interest expenses
-472,00 ათ.
-536,00 ათ.
-509,00 ათ.
Depreciation and amortization charges
-
-
-
EBITDA
-6,49 მლნ.
-4,80 მლნ.
-4,32 მლნ.
Gain or loss from assets sale
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები